 |
|
Sex Differences in the Use of Implantable Cardioverter-Defibrillators for Primary and Secondary Prevention of Sudden Cardiac Death
Lesley H. Curtis, PhD;
Sana M. Al-Khatib, MD, MHS;
Alisa M. Shea, MPH;
Bradley G. Hammill, MS;
Adrian F. Hernandez, MD, MHS;
Kevin A. Schulman, MD
JAMA. 2007;298:1517-1524.
Context Previous studies of sex differences in the use of implantable cardioverter-defibrillators (ICDs) predate recent expansions in Medicare coverage and did not provide patient follow-up over multiple years.
Objective To examine sex differences in ICD use for primary and secondary prevention of sudden cardiac death.
Design, Setting, and Participants Analysis of a 5% national sample of research-identifiable files obtained from the US Centers for Medicare & Medicaid Services for the period 1991 through 2005. Patients were those aged 65 years or older with Medicare fee-for-service coverage and diagnosed with acute myocardial infarction and either heart failure or cardiomyopathy but no prior cardiac arrest or ventricular tachycardia (ie, the primary prevention cohort [n = 65 917 men and 70 504 women]), or with cardiac arrest or ventricular tachycardia (ie, the secondary prevention cohort [n = 52 252 men and 47 411 women]), from 1999 through 2005.
Main Outcome Measures Receipt of ICD therapy and all-cause mortality at 1 year.
Results In the 2005 primary prevention cohort, 32.3 per 1000 men and 8.6 per 1000 women received ICD therapy within 1 year of cohort entry. In multivariate analyses, men were more likely than women to receive ICD therapy (hazard ratio [HR], 3.15; 95% confidence interval [CI], 2.86-3.47). Among men and women alive at 180 days after cohort entry, the hazard of mortality in the subsequent year was not significantly lower among those who received ICD therapy (HR, 1.01; 95% CI, 0.82-1.23). In the 2005 secondary prevention cohort, 102.2 per 1000 men and 38.4 per 1000 women received ICD therapy. Controlling for demographic variables and comorbid conditions, men were more likely than women to receive ICD therapy (HR, 2.44; 95% CI, 2.30-2.59). Among men and women alive at 30 days after cohort entry, the hazard of mortality in the subsequent year was significantly lower among those who received ICD therapy (HR, 0.65; 95% CI, 0.60-0.71).
Conclusion In the Medicare population, women are significantly less likely than men to receive ICD therapy for primary or secondary prevention of sudden cardiac death.
Author Affiliations: Duke Clinical Research Institute (Drs Curtis, Al-Khatib, Hernandez, and Schulman and Ms Shea and Mr Hammill) and Department of Medicine (Drs Curtis, Al-Khatib, Hernandez, and Schulman), Duke University School of Medicine, Durham, North Carolina.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLES
Sex and Racial Differences in the Use of Implantable Cardioverter-Defibrillators Among Patients Hospitalized With Heart Failure
Adrian F. Hernandez, Gregg C. Fonarow, Li Liang, Sana M. Al-Khatib, Lesley H. Curtis, Kenneth A. LaBresh, Clyde W. Yancy, Nancy M. Albert, and Eric D. Peterson
JAMA. 2007;298(13):1525-1532.
ABSTRACT
| FULL TEXT
Disparities in Use of Implantable Cardioverter-Defibrillators: Moving Beyond Process Measures to Outcomes Data
Rita F. Redberg
JAMA. 2007;298(13):1564-1566.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Women Have a Lower Prevalence of Structural Heart Disease as a Precursor to Sudden Cardiac Arrest The Ore-SUDS (Oregon Sudden Unexpected Death Study).
Chugh et al.
J Am Coll Cardiol 2009;54:2006-2011.
ABSTRACT
| FULL TEXT
Do gender differences exist in pacemaker implantation?--results of an obligatory external quality control program
Nowak et al.
Europace 2009;0:eup312v1-eup312.
ABSTRACT
| FULL TEXT
Effectiveness of Implantable Cardioverter-Defibrillators for the Primary Prevention of Sudden Cardiac Death in Women With Advanced Heart Failure: A Meta-analysis of Randomized Controlled Trials
Ghanbari et al.
Arch Intern Med 2009;169:1500-1506.
ABSTRACT
| FULL TEXT
Predicting Sudden Death in the General Population: Another Step, N Terminal B-Type Natriuretic Factor Levels
Chugh and Reinier
Circulation 2009;119:2863-2864.
FULL TEXT
The Year in Epidemiology, Health Services Research, and Outcomes Research
Hlatky and Heidenreich
J Am Coll Cardiol 2009;53:1459-1466.
FULL TEXT
Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI)
Santini et al.
Europace 2009;11:476-482.
ABSTRACT
| FULL TEXT
Hospital Variation and Characteristics of Implantable Cardioverter-Defibrillator Use in Patients With Heart Failure Data From the GWTG-HF (Get With The Guidelines-Heart Failure) Registry.
Shah et al.
J Am Coll Cardiol 2009;53:416-422.
ABSTRACT
| FULL TEXT
Heart Disease and Stroke Statistics--2009 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
WRITING GROUP MEMBERS et al.
Circulation 2009;119:e21-e181.
FULL TEXT
Impact of Age and Medical Comorbidity on the Effectiveness of Implantable Cardioverter-Defibrillators for Primary Prevention
Chan et al.
Circ Cardiovasc Qual Outcomes 2009;2:16-24.
ABSTRACT
| FULL TEXT
Use of Prescription and Over-the-counter Medications and Dietary Supplements Among Older Adults in the United States
Qato et al.
JAMA 2008;300:2867-2878.
ABSTRACT
| FULL TEXT
Patient-Predicted Life Expectancy Among Ambulatory Patients With Heart Failure--Reply
Allen et al.
JAMA 2008;300:2117-2117.
FULL TEXT
Use of Cardiac Resynchronization Therapy in Patients Hospitalized With Heart Failure
Piccini et al.
Circulation 2008;118:926-933.
ABSTRACT
| FULL TEXT
Sex Differences in Congenital Heart Disease: Should a Woman Be More Like a Man?
Warnes
Circulation 2008;118:3-5.
FULL TEXT
Kidney Dysfunction and Sudden Cardiac Death Among Women With Coronary Heart Disease
Deo et al.
Hypertension 2008;51:1578-1582.
ABSTRACT
| FULL TEXT
Sex matters: gender disparities in quality and outcomes of care
Bierman
CMAJ 2007;177:1520-1521.
FULL TEXT
Racial and Gender Disparities in Use of ICDs
JWatch Emergency Med. 2007;2007:4-4.
FULL TEXT
Disparities in Use of Implantable Cardioverter-Defibrillators: Moving Beyond Process Measures to Outcomes Data
Redberg
JAMA 2007;298:1564-1566.
FULL TEXT
Sex, Race, and Implantable Cardioverter-Defibrillators
Journal Watch Cardiology 2007;2007:4-4.
FULL TEXT
|
